FI903366A0 - FOERFARANDE FOER FRAMSTAELLNING AV EN MYCKET REN ICKE INFEKTIOES ANTIHEMOFILIFAKTOR GENOM KROMATOGRAFI. - Google Patents

FOERFARANDE FOER FRAMSTAELLNING AV EN MYCKET REN ICKE INFEKTIOES ANTIHEMOFILIFAKTOR GENOM KROMATOGRAFI.

Info

Publication number
FI903366A0
FI903366A0 FI903366A FI903366A FI903366A0 FI 903366 A0 FI903366 A0 FI 903366A0 FI 903366 A FI903366 A FI 903366A FI 903366 A FI903366 A FI 903366A FI 903366 A0 FI903366 A0 FI 903366A0
Authority
FI
Finland
Prior art keywords
kromatografi
infektioes
antihemofilifaktor
mycket
icke
Prior art date
Application number
FI903366A
Other languages
Finnish (fi)
Inventor
Andrew Smith
Original Assignee
Octapharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8199529&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI903366(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Octapharma Ag filed Critical Octapharma Ag
Publication of FI903366A0 publication Critical patent/FI903366A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Chemical Vapour Deposition (AREA)
  • Intermediate Stations On Conveyors (AREA)

Abstract

A process for producing a high-purity, non-infectious antihaemophilia factor (AHF or factor VIII) from blood plasma by treating a fraction enriched with factor VIII with biocompatible organic solvents/detergents followed by further cleaning steps is characterized in that the fraction enriched with factor VIII is obtained by a chromatographic process. After removal of viruses, said fraction advantageously undergoes further gel permeation chromatography with ion-exchange materials.
FI903366A 1988-11-05 1990-07-04 FOERFARANDE FOER FRAMSTAELLNING AV EN MYCKET REN ICKE INFEKTIOES ANTIHEMOFILIFAKTOR GENOM KROMATOGRAFI. FI903366A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP88118478A EP0367840B1 (en) 1988-11-05 1988-11-05 Process for producing by chromatography a non-infectious antihemophilic factor with high purity
PCT/EP1989/001247 WO1990005140A1 (en) 1988-11-05 1989-10-19 Process for producing a high-purity, non-infectious antihaemophilia factor by chromatography

Publications (1)

Publication Number Publication Date
FI903366A0 true FI903366A0 (en) 1990-07-04

Family

ID=8199529

Family Applications (1)

Application Number Title Priority Date Filing Date
FI903366A FI903366A0 (en) 1988-11-05 1990-07-04 FOERFARANDE FOER FRAMSTAELLNING AV EN MYCKET REN ICKE INFEKTIOES ANTIHEMOFILIFAKTOR GENOM KROMATOGRAFI.

Country Status (8)

Country Link
EP (1) EP0367840B1 (en)
JP (1) JPH03502200A (en)
AT (1) ATE85221T1 (en)
DE (1) DE3878245D1 (en)
DK (1) DK161590D0 (en)
ES (1) ES2053684T3 (en)
FI (1) FI903366A0 (en)
WO (1) WO1990005140A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4008852A1 (en) * 1990-03-20 1991-09-26 Octapharma Ag METHOD FOR PRODUCING NON-INFECTIOUS BLOOD PLASMA
IT1248723B (en) * 1990-06-12 1995-01-26 Scalvo S P A PROCESS FOR THE PURIFICATION OF FACTOR VIII AND FACTOR VIII OBTAINED WITH SUCH PROCESS
FR2681867B1 (en) * 1991-09-26 1993-12-31 Pasteur Merieux Serums Vaccins FACTOR VIII PURIFICATION PROCESS AND PREPARATIONS OBTAINED.
DE4204694C3 (en) * 1992-02-01 1995-10-12 Octapharma Ag Method for obtaining highly pure, virus-inactivated factor VIII by means of anion exchange chromatography
AT399818B (en) * 1992-04-24 1995-07-25 Immuno Ag METHOD FOR PRODUCING A HIGH PURIFIED VIRUS-SAFE FACTOR VIII PREPARATION
IT1256622B (en) * 1992-12-04 1995-12-12 Sclavo Spa PROCESS FOR THE EXTRACTION OF THE FACTOR VIII-FACTOR VON WILLEBRAND (FVIII: C-FVW) FROM TOTAL HUMAN PLASMA.
WO1994017834A1 (en) * 1993-02-09 1994-08-18 Octapharma Ag Method for inactivating viruses devoid of lipid envelopes
SE9301582D0 (en) * 1993-05-07 1993-05-07 Kabi Pharmacia Ab PURIFICATION OF PLASMA PROTEINS
DE4337573C1 (en) * 1993-11-04 1995-05-18 Octapharma Ag Process for the preparation of a virus-inactivated factor VIII-containing fraction by means of chromatographic methods
AT407159B (en) † 1997-06-13 2001-01-25 Immuno Ag METHOD FOR DEPOSITING VIRALS AND MOLECULAR PATHOGENS FROM A BIOLOGICAL MATERIAL
AU5678500A (en) * 1999-06-08 2000-12-28 Octapharma Ag Process for removing viruses from biological samples
EP1148063A1 (en) 2000-04-18 2001-10-24 Octapharma AG Composition containing hemostatic activ vWF and process for its preparation

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE713764A (en) 1967-05-01 1968-09-16 Baxter Travenol Lab
JPS52125609A (en) 1976-04-09 1977-10-21 Green Cross Corp:The Purification of agglutination factor viii
DE2635894A1 (en) * 1976-08-10 1978-02-16 Biotest Serum Institut Gmbh Prepn. of concentrates contg. anti-haemophilic globulin:A - by adsorption onto di:ethylamino-ethyl-cellulose from plasma etc., then elution with buffer
US4386068A (en) * 1980-02-26 1983-05-31 Cutter Laboratories, Inc. Antihemophilic factor concentrate and method for preparation
US4495175A (en) 1982-08-05 1985-01-22 University Of Rochester Preparation of highly purified human antihemophilic factor
US4540573A (en) 1983-07-14 1985-09-10 New York Blood Center, Inc. Undenatured virus-free biologically active protein derivatives
US4478825A (en) * 1983-10-14 1984-10-23 Armour Pharmaceutical Company Warm ethanol method for preparation of low fibrinogen antihemophilic factor
US4508709A (en) * 1983-12-05 1985-04-02 Armour Pharmaceutical Company Process for purifying factor VIII:C
DE3432083A1 (en) 1984-08-31 1986-03-06 Behringwerke Ag, 3550 Marburg PASTEURIZED, ISOAGGLUTININ-FREE FACTOR VIII PREPARATION AND METHOD FOR THE PRODUCTION THEREOF
US4743680A (en) 1985-02-01 1988-05-10 New York University Method for purifying antihemophilic factor
EP0238701B1 (en) * 1986-03-27 1992-03-18 Octapharma AG Process for the production of a highly purified anti-haemophilia factor
US4789545A (en) 1986-03-31 1988-12-06 New York Blood Center, Inc. Removal of lipid soluble process chemicals from biological materials by extraction with naturally occurring oils or synthetic substitutes thereof
JPS63108000A (en) * 1986-05-15 1988-05-12 Green Cross Corp:The Purification of factor viii
EP0343275B1 (en) 1988-05-27 1993-02-03 Centre Regional De Transfusion Sanguine De Lille Process for the production of a high purity, virus-free antihaemophilic factor by means of chromatography

Also Published As

Publication number Publication date
JPH03502200A (en) 1991-05-23
DK161590A (en) 1990-07-04
EP0367840B1 (en) 1993-02-03
ES2053684T3 (en) 1994-08-01
DE3878245D1 (en) 1993-03-18
EP0367840A1 (en) 1990-05-16
WO1990005140A1 (en) 1990-05-17
ATE85221T1 (en) 1993-02-15
DK161590D0 (en) 1990-07-04

Similar Documents

Publication Publication Date Title
FI903366A0 (en) FOERFARANDE FOER FRAMSTAELLNING AV EN MYCKET REN ICKE INFEKTIOES ANTIHEMOFILIFAKTOR GENOM KROMATOGRAFI.
ATE72121T1 (en) PROCESS FOR THE PRODUCTION OF APOLIPOPROTEINS FROM BLOOD PLASMA OR SERUM FRACTIONS.
DE68919466D1 (en) Process for the manufacture of helical, glass fiber reinforced fasteners.
DE69013313D1 (en) Multi-stage process for the production of hexafluoropropylene.
NO920834L (en) PROCEDURE FOR INACTIVATION OF VIRUS IN BLOOD AND BLOOD PRODUCTS
DE69008326D1 (en) Multi-stage process for the production of hexafluoropropylene.
DE68915676D1 (en) Process for the production of lenses.
DE69101156D1 (en) A process for the production of modified adsorbing carbon molecular sieves.
BR9004626A (en) PROCESS FOR PREPARING A VON WILLEBRAND FACTOR VIII-FACTOR STAINLESS CONCENTRATE, VON WILLEBRAND FACTOR VIII-FACTOR CONCENTRATE AND PLASMA-DERIVED PROTEIN CONCENTRATES
ES2147898T3 (en) REGENERATION OF MOLECULAR SCREEN CONTAINING TITANIUM.
DE69010171D1 (en) Multi-stage process for the production of hexafluoropropylene.
ATE166881T1 (en) METHOD FOR PRODUCING FACTOR VIII
FI101228B1 (en) Process for preparing purified albumin solutions
ATE78239T1 (en) PROCESS FOR THE PRODUCTION OF ZEOLITES.
DE68920351D1 (en) Process for the production of indigo compounds.
DE69317237D1 (en) Process for the production of abrasion-resistant, transparent parts
ES2055875T3 (en) MANUFACTURING PROCEDURE OF THE ANTIHEMOPHILIC FACTOR (FVIIIC) WITH A VERY HIGH PURITY.
FI961900A0 (en) Method for the preparation of a virus-inactivated factor VIII-containing fraction by chromatographic methods
DE59208707D1 (en) Process for the purification of streptolysin 0, intact streptolysin 0 obtainable by this process and its use
ES2117197T3 (en) PROCEDURE FOR THE EXTRACTION AND PURIFICATION OF ALFA1-ANTI-TRYPSINE (ALFA1-PI) FROM THE COHN IV-1 FRACTION.
DE59005407D1 (en) Process for the preparation of fiber-reactive formazan compounds.
HUT59312A (en) Process for producing pharmaceutical preparative containing n-methyl-2-(3-pyridyl)-tetrahydropyrane-2-carbothioamide-1-oxide applicable for treating insufficiency of coronary arteries
DE68918226D1 (en) Process for the production of indigo compounds.
AU5603886A (en) A process for the control of odours in a vapour stream
IT8921140A0 (en) PROCESS FOR THE PREPARATION OF ASPARTYLATED PROTEINATE.

Legal Events

Date Code Title Description
FD Application lapsed
FD Application lapsed

Owner name: OCTAPHARMA AG